TG THERAPEUTICS, INC.·4

Aug 14, 9:54 AM ET

WEISS MICHAEL S 4

4 · TG THERAPEUTICS, INC. · Filed Aug 14, 2023

Insider Transaction Report

Form 4
Period: 2023-08-11
WEISS MICHAEL S
DirectorCEO
Transactions
  • Purchase

    COMMON STOCK

    2023-08-11$10.13/sh+100,000$1,013,00012,073,021 total
Footnotes (2)
  • [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.11 to $10.17. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Includes shares of restricted Common Stock, which vest over various time periods.

Documents

1 file
  • 4
    tm2323684-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT